Results 41 to 50 of about 830,862 (265)
Molecular Oncology, EarlyView.In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera +11 more
wiley +1 more source
Evaluation and Prioritization of Hospital Management Roles from Experts\' Point of View (Study Case: Imam Khomeini Hospital (RA)) [PDF]
بیمارستان, 2023 Background: Achieving goals and developing hospital services depends on competence and optimal management. There will be competent managers who can be successful in performing managerial roles.
Rohollh Hosseini, Anis Javanmard
doaj
Molecular Oncology, EarlyView.RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner +14 more
wiley +1 more source
Hospital wastes management in Mazandaran Province with emphasis on genotoxic waste management
سلامت و محیط, 2019 Background and Objective: Hospital wastes with the content of infectious, pathologic, sharp, pharmaceupitical and genotoxic materials are classified as hazardous wastes.
J Gorgani +7 more
doaj
The Use of RFID in Hospital Systems: An Analysis of International Journals
GEPROS: Gestão da Produção, Operações e Sistemas, 2019 The flow of people, materials and equipment in hospitals is high, making its management a complex task, since care must be taken to ensure the life and safety of patients.
Isabela Maria Monteiro Vieira +4 more
doaj +1 more source
Molecular Oncology, EarlyView.This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
Molecular Oncology, EarlyView.Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Medicine demand forecasting: an assessment of a private hospital in Pernambuco
Socioeconomic AnalyticsThe efficient management of materials in the healthcare sector is crucial to avoid interruptions in the treatment of hospitalized patients, especially when demand is unpredictable and based on criteria of criticality, urgency and clinical status.
Eduardo Fernando da Silva Souza +1 more
doaj +1 more source
Molecular Oncology, EarlyView.Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach +9 more
wiley +1 more source
CEACAM1 participation in breast cancer progression
Molecular Oncology, EarlyView.In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin +3 more
wiley +1 more source